Endocrine disruptor assessment list

Endocrine disruptor assessment list

Endocrine disruptor assessment list

ECHA’s endocrine disruptor (ED) assessment list includes the substances undergoing an ED assessment under REACH or the Biocidal Products Regulation that have been brought for discussion to ECHA’s ED Expert Group

Explanatory note

For REACH substances, inclusion in the list means that an informal hazard assessment for endocrine-disrupting properties either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing or evaluating Member State (submitter), the outcome from the assessment, and the date of the latest update to the list entry.

Other process details and hazard assessment outcome documents are also available and can be accessed through the ‘Details’ icon.

One possible outcome of such an assessment is that a substance is considered not to have ED properties.

If the outcome is that the substance is considered to have ED properties, confirmation through the formal risk management and decision-making processes under REACH/BPR is needed before any regulatory action can be taken due to these properties.

The intentions of authorities to submit a dossier to the formal REACH and CLP processes are notified through the Registry of Intentions. All biocidal active substances have to undergo a formal ED assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.

Disclaimer

The information and views set out in the ED assessment list and in the hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use, which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. ED assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.

Last updated 16 September 2022. Database contains 107 unique substances/entries.
Filter the list
Date of hazard assessment:
Date of intention:
Latest update:

The List does not contain any Substances.
 
239-139-9
15087-24-8
Germany
Concluded
ED ENV
03-Feb-2021
Details
262-104-4
60207-90-1
Finland
Concluded
ED ENV
ED HH
23-May-2022
Details
233-539-7
10222-01-2
Denmark
Concluded
ED ENV
ED HH
08-Mar-2021
Details
201-025-1
77-40-7
France
Concluded
ED ENV
ED HH
27-Sep-2021
Details
201-245-8
80-05-7
Germany
Concluded
ED ENV
03-Feb-2021
Details
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
Phenol, heptyl derivs. EC / List no: 276-743-1 | CAS no: 72624-02-3
4-heptylphenol EC / List no: 217-862-0 | CAS no: 1987-50-4
4-(3-ethylpentan-3-yl)phenol EC / List no: - | CAS no: 37872-24-5
4-(2-methylhexan-2-yl)phenol EC / List no: - | CAS no: 30784-31-7
4-(3,3-dimethylpentan-2-yl)phenol EC / List no: - | CAS no: 911371-06-7
4-(3-methylhexan-2-yl)phenol EC / List no: - | CAS no: 854904-93-1
4-(4,4-dimethylpentan-2-yl)phenol EC / List no: - | CAS no: 911371-07-8
4-(4-methylhexan-2-yl)phenol EC / List no: - | CAS no: 71945-81-8
4-(5-methylhexan-2-yl)phenol EC / List no: - | CAS no: 857629-71-1
4-(2,2-dimethylpentan-3-yl)phenol EC / List no: - | CAS no: 861010-65-3
4-(3-methylhexan-3-yl)phenol EC / List no: 854-958-7 | CAS no: 30784-32-8
4-(heptan-3-yl)phenol EC / List no: - | CAS no: 6465-74-3
4-(heptan-2-yl)phenol EC / List no: - | CAS no: 6863-24-7
4-(heptan-4-yl)phenol EC / List no: - | CAS no: 6465-71-0
4-(3-ethylpentyl)phenol EC / List no: - | CAS no: 911370-98-4
4-(3-methylhexyl)phenol EC / List no: - | CAS no: 102570-52-5
4-(4-methylhexyl)phenol EC / List no: - | CAS no: 1139800-98-8
4-(5-methylhexyl)phenol EC / List no: - | CAS no: 100532-36-3
4-(2,4-dimethylpentan-3-yl)phenol EC / List no: - | CAS no: 1824346-00-0
Phenol, 4-tert-heptyl- EC / List no: - | CAS no: 288864-02-8
Phenol, 4-(1-ethyl-1,2-dimethylpropyl)- EC / List no: - | CAS no: 30784-27-1
4-(2,3-dimethylpentan-2-yl)phenol EC / List no: 854-135-2 | CAS no: 861011-60-1
4-(2,4-dimethylpentan-2-yl)phenol EC / List no: - | CAS no: 33104-11-9
4-(2,3,3-trimethylbutan-2-yl)phenol EC / List no: - | CAS no: 72861-06-4
4-(5-methylhexan-3-yl)phenol EC / List no: - | CAS no: 854904-92-0
-
-
Austria
Concluded
ED ENV
03-Feb-2021
Details
202-679-0
98-54-4
Germany
Concluded
ED ENV
16-Sep-2022
Details
232-235-1
7790-98-9
Germany
Concluded
ED ENV
03-Feb-2021
Details
206-992-3
420-04-2
Germany
Concluded
ED ENV
ED HH
08-Mar-2021
Details
201-280-9
80-46-6
Germany
Concluded
ED ENV
ED HH
03-Feb-2021
Details
show/hide
phenol, (tetrapropenyl) derivatives EC / List no: 616-100-8 | CAS no: 74499-35-7
Phenol, 4-isododecyl- EC / List no: 608-055-8 | CAS no: 27147-75-7
Phenol, tetrapropylene- EC / List no: - | CAS no: 57427-55-1
phenol, 4-dodecyl-, branched EC / List no: 640-104-9 | CAS no: 210555-94-5
[No public or meaningful name is available] EC / List no: - | CAS no: 27459-10-5
Phenol, dodecyl-, branched EC / List no: 310-154-3 | CAS no: 121158-58-5
799-972-3
-
Germany
Concluded
ED ENV
ED HH
27-Sep-2021
Details
310-154-3
121158-58-5
Germany
Concluded
ED ENV
ED HH
03-Feb-2021
Details
231-511-9
7601-89-0
Germany
Concluded
ED ENV
03-Feb-2021
Details
-
-
Denmark
Concluded
ED HH
04-Aug-2022
Details
201-245-8
80-05-7
France
Concluded
ED HH
03-Feb-2021
Details
202-318-7
94-26-8
Denmark
Concluded
ED HH
27-Sep-2021
Details
201-545-9
84-61-7
Sweden
Concluded
ED HH
03-Feb-2021
Details
216-823-5
1675-54-3
Denmark
Concluded
inconclusive
15-Mar-2022
Details
201-289-8
80-54-6
Sweden
Concluded
inconclusive
10-Mar-2022
Details
203-585-2
108-46-3
Finland
Concluded
inconclusive
03-Feb-2021
Details
216-653-1
1634-04-4
France
Concluded
inconclusive
10-Mar-2022
Details
229-962-1
6864-37-5
Germany
Concluded
not ED
27-Jun-2022
Details
200-843-6
75-15-0
France
Concluded
not ED
18-May-2022
Details
203-398-6
106-44-5
United Kingdom
Concluded
not ED
07-Mar-2017
Details
202-830-0
100-21-0
France
Concluded
not ED
11-Dec-2015
Details
205-286-2
137-26-8
Sweden
Concluded
not ED
24-Oct-2018
Details
201-067-0
77-90-7
France
Concluded
not ED
19-Dec-2016
Details
306-832-3
97416-84-7
Germany
Postponed
postponed
05-Jan-2022
Details
244-617-5
21850-44-2
Germany
Postponed
postponed
05-Jan-2022
Details
206-022-9
288-88-0
Belgium
Postponed
postponed
26-May-2021
Details
252-615-0
35554-44-0
Germany
Concluded
postponed
11-Nov-2021
Details
627-872-0
1514-82-5
Spain
Postponed
postponed
10-Sep-2020
Details
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
400-600-6
71868-10-5
Austria
Concluded
postponed
05-Nov-2021
Details
201-126-0
78-59-1
France
Postponed
postponed
26-Jul-2022
Details
428-970-4
13595-25-0
Belgium
Postponed
postponed
12-May-2017
Details
1 - 4.5 moles propoxylated
500-097-4
37353-75-6
Denmark
Postponed
postponed
18-Jan-2021
Details
201-248-4
80-08-0
Germany
Concluded
postponed
05-Nov-2021
Details
200-838-9
75-09-2
Italy
Concluded
postponed
03-Sep-2021
Details
204-317-7
119-36-8
France
Postponed
postponed
26-May-2021
Details
202-716-0
98-95-3
Austria
Concluded
postponed
05-Nov-2021
Details
1 - 2.5 moles ethoxylated
500-209-1
68412-54-4
United Kingdom
Concluded
postponed
05-Nov-2021
Details
219-006-1
2312-35-8
Netherlands
Postponed
postponed
03-Nov-2020
Details
214-619-0
1166-46-7
Germany
Under development
Under development (BPR)
03-Feb-2021
Details
259-627-5
55406-53-6
Denmark
Under development
Under development (BPR)
03-Feb-2021
Details
ETHOFENPROX; TREBON
407-980-2
80844-07-1
Austria
Under development
Under development (BPR)
03-Feb-2021
Details
240-016-7
15879-93-3
Poland
Under development
Under development (BPR)
03-Feb-2021
Details
234-217-9
10599-90-3
Sweden
Under development
Under development (BPR)
22-Oct-2021
Details
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Chrysanthemum cinerariaefolium, Compositae.
289-699-3
89997-63-7
Spain
Under development
Under development (BPR)
05-Feb-2021
Details
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Chrysanthemum cinerariaefolium, Compositae.
289-699-3
89997-63-7
Spain
Under development
Under development (BPR)
05-Feb-2021
Details
231-159-6
7440-50-8
France
Under development
Under development (BPR)
03-Feb-2021
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.